More Smart Use of Direct Oral Anticoagulants in Geriatric Patients [Letter].
作者信息
Zhu Ling-Ling, Zhou Quan
机构信息
Geriatric VIP Ward, Division of Nursing, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, People's Republic of China.
Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, People's Republic of China.
出版信息
Drug Des Devel Ther. 2023 Sep 6;17:2747-2748. doi: 10.2147/DDDT.S436943. eCollection 2023.
Abstract
摘要
相似文献
1
More Smart Use of Direct Oral Anticoagulants in Geriatric Patients [Letter].老年患者直接口服抗凝剂的更明智使用[信函]
Drug Des Devel Ther. 2023 Sep 6;17:2747-2748. doi: 10.2147/DDDT.S436943. eCollection 2023.
2
Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.老年因素与老年心房颤动患者口服抗凝药物的应用：SAGE-AF。
J Am Geriatr Soc. 2020 Jan;68(1):147-154. doi: 10.1111/jgs.16178. Epub 2019 Oct 1.
3
Oral anticoagulant treatment in geriatric patients with nonvalvular atrial fibrillation in the era of direct oral anticoagulant agents.直接口服抗凝剂时代老年非瓣膜性心房颤动患者的口服抗凝治疗
Eur J Intern Med. 2014 Jun;25(5):e63-5. doi: 10.1016/j.ejim.2014.02.003. Epub 2014 Feb 23.
4
Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation.非维生素K拮抗剂类抗凝剂的引入显著提高了老年房颤住院患者的抗凝率。
Drugs Aging. 2018 Sep;35(9):859-869. doi: 10.1007/s40266-018-0571-1.
5
Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS Score ≥ 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants?CHA₂DS₂-VASc评分≥2分的老年房颤患者抗凝治疗不足：自直接口服抗凝药上市以来我们做得更好了吗？
Drugs Aging. 2017 Nov;34(11):841-850. doi: 10.1007/s40266-017-0493-3.
6
Direct oral anticoagulants in non-valvular atrial fibrillation in elderly: for a treatment adapted to patient profile.老年非瓣膜性心房颤动患者使用直接口服抗凝剂：实现个体化治疗。
Geriatr Psychol Neuropsychiatr Vieil. 2018 Sep 1;16(3):229-240. doi: 10.1684/pnv.2018.0746.
7
Use of oral anticoagulants in complex clinical situations with atrial fibrillation.在伴有房颤的复杂临床情况下使用口服抗凝药物。
Med Clin (Barc). 2018 Jun;150 Suppl 1:8-24. doi: 10.1016/S0025-7753(18)30666-3.
8
[Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].[口服抗凝剂治疗心房颤动的老年人的生活质量：维生素K拮抗剂与直接口服抗凝剂的比较]
Geriatr Psychol Neuropsychiatr Vieil. 2015 Mar;13(1):45-54. doi: 10.1684/pnv.2015.0516.
9
Novel oral anticoagulants for stroke prevention in the geriatric population.新型口服抗凝药物在老年人群卒中预防中的应用。
Am J Cardiovasc Drugs. 2014 Feb;14(1):15-29. doi: 10.1007/s40256-013-0050-3.
10
The use of new oral anticoagulants in geriatric patients: A survey study for physicians.老年患者新型口服抗凝药的应用：一项针对医生的调查研究。
Tuberk Toraks. 2021 Mar;69(1):65-73. doi: 10.5578/tt.20219908.
本文引用的文献
1
Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban.基因多态性可能会影响服用阿哌沙班和利伐沙班的患者的出血风险。
Drug Des Devel Ther. 2023 Aug 23;17:2513-2522. doi: 10.2147/DDDT.S417096. eCollection 2023.
2
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.美国老年医学学会 2023 年更新了老年人潜在不适当药物使用的 AGS Beers 标准®。
J Am Geriatr Soc. 2023 Jul;71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4.
3
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.美国老年医学学会 2019 年更新的老年人潜在不适当药物使用 AGS Beers 标准®。
J Am Geriatr Soc. 2019 Apr;67(4):674-694. doi: 10.1111/jgs.15767. Epub 2019 Jan 29.
Zotero 插件